These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32327161)

  • 1. Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple Myeloma.
    Cope S; Toor K; Popoff E; Fonseca R; Landgren O; Mateos MV; Weisel K; Jansen JP
    Value Health; 2020 Apr; 23(4):441-450. PubMed ID: 32327161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Efficacy of Treatments for Previously Treated Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis.
    Maiese EM; Ainsworth C; Le Moine JG; Ahdesmäki O; Bell J; Hawe E
    Clin Ther; 2018 Mar; 40(3):480-494.e23. PubMed ID: 29500140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence synthesis in pulmonary arterial hypertension: a systematic review and critical appraisal.
    Schlueter M; Beaudet A; Davies E; Gurung B; Karabis A
    BMC Pulm Med; 2020 Jul; 20(1):202. PubMed ID: 32723397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of several matching adjusted indirect comparisons (MAICs) with an application in psoriasis.
    Saure D; Schacht A; Kadziola Z; Brnabic AJM
    Pharm Stat; 2020 Sep; 19(5):532-540. PubMed ID: 32115845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials.
    Cope S; Clemens A; Hammès F; Noack H; Jansen JP
    Value Health; 2015 Mar; 18(2):234-49. PubMed ID: 25773559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scoping review of indirect comparison methods and applications using individual patient data.
    Veroniki AA; Straus SE; Soobiah C; Elliott MJ; Tricco AC
    BMC Med Res Methodol; 2016 Apr; 16():47. PubMed ID: 27116943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
    Hoaglin DC; Hawkins N; Jansen JP; Scott DA; Itzler R; Cappelleri JC; Boersma C; Thompson D; Larholt KM; Diaz M; Barrett A
    Value Health; 2011 Jun; 14(4):429-37. PubMed ID: 21669367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect modification in network meta-analyses for relapsed/refractory multiple myeloma: systematic review and meta-analysis.
    Rose CJ; Ohm IK; Giske L; Næss GE; Fretheim A
    BMJ Open; 2023 Aug; 13(8):e067966. PubMed ID: 37643851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vibration of effects resulting from treatment selection in mixed-treatment comparisons: a multiverse analysis on network meta-analyses of antidepressants in major depressive disorder.
    Vinatier C; Palpacuer C; Scanff A; Naudet F
    BMJ Evid Based Med; 2024 Sep; 29(5):324-332. PubMed ID: 38769000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ixazomib for Relapsed or Refractory Multiple Myeloma: Review from an Evidence Review Group on a NICE Single Technology Appraisal.
    Armoiry X; Connock M; Tsertsvadze A; Cummins E; Melendez-Torres GJ; Royle P; Clarke A
    Pharmacoeconomics; 2018 Sep; 36(9):1073-1081. PubMed ID: 29582405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the impact of a matching-adjusted indirect comparison in a Bayesian network meta-analysis.
    Leahy J; Walsh C
    Res Synth Methods; 2019 Dec; 10(4):546-568. PubMed ID: 31368653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods to appraise available evidence and adequacy of data from a systematic literature review to conduct a robust network meta-analysis of treatment options for patients with hospital-acquired or ventilator-associated bacterial pneumonia.
    Puzniak L; Dillon R; Lodise T
    PLoS One; 2023; 18(1):e0279844. PubMed ID: 36598902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta-analyses and real-world evidence on antiepileptic drugs.
    Thieffry S; Klein P; Baulac M; Plumb J; Pelgrims B; Steeves S; Borghs S
    Epilepsia; 2020 Apr; 61(4):595-609. PubMed ID: 32201951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost Offsets in the Treatment Journeys of Patients With Relapsed/Refractory Multiple Myeloma.
    Ailawadhi S; DerSarkissian M; Duh MS; Lafeuille MH; Posner G; Ralston S; Zagadailov E; Ba-Mancini A; Rifkin R
    Clin Ther; 2019 Mar; 41(3):477-493.e7. PubMed ID: 30773308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma.
    Martin T; Usmani SZ; Schecter JM; Roccia T; Jackson CC; Deraedt W; Yeh TM; Banerjee A; Pacaud L; Garrett A; Bartlett M; Haltner A; Van Sanden S; Diels J; Valluri S; Samjoo IA
    Curr Med Res Opin; 2023 Jan; 39(1):81-89. PubMed ID: 36271807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.
    Jansen JP; Fleurence R; Devine B; Itzler R; Barrett A; Hawkins N; Lee K; Boersma C; Annemans L; Cappelleri JC
    Value Health; 2011 Jun; 14(4):417-28. PubMed ID: 21669366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Relative-Efficacy Estimate(S) Derived From Both Matching-Adjusted Indirect Comparisons and Standard Anchored Indirect Treatment Comparisons: A Review of Matching-Adjusted Indirect Comparisons.
    Cassidy O; Harte M; Trela-Larsen L; Walsh C; White A; McCullagh L; Leahy J
    Value Health; 2023 Nov; 26(11):1665-1674. PubMed ID: 37460009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.
    Büyükkaramikli NC; de Groot S; Fayter D; Wolff R; Armstrong N; Stirk L; Worthy G; Albuquerque de Almeida F; Kleijnen J; Al MJ
    Pharmacoeconomics; 2018 Feb; 36(2):145-159. PubMed ID: 29086363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysis.
    Weisel K; Sonneveld P; Spencer A; Beksac M; Rizzo M; Xu Y; Fahrbach K; Gaudig M; Slavcev M; Dearden L; Lam A
    Leuk Lymphoma; 2019 Jan; 60(1):151-162. PubMed ID: 30407092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.